SC 13G
COGENT BIOSCIENCES, INC.
- Company
- Cogent Biosciences, Inc.
- Filed
- June 1, 2023
- Accession Number
- 0000902664-23-003363
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →